Literature DB >> 19057395

Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006).

Jesús K Yamamoto-Furusho1.   

Abstract

BACKGROUND: Ulcerative colitis (UC) is a chronic disease with a heterogeneous clinical evolution. The prevalence and incidence of UC vary widely and depend on multiple factors including ethnicity and geographic location. GOAL: To determine the frequency of new cases of UC and their clinical characteristics in a large cohort from a referral hospital in Mexico City. STUDY: Patients with confirmed diagnosis of UC were included during a period between January 1987 and December 2006. Demographic and clinical data were collected from medical records.
RESULTS: A total of 848 new cases of UC were diagnosed during a 20-year period. All the patients had endoscopic and histologic confirmation. The mean of annual new UC cases increased from 28.8 in the first period (1987 to 1996) to 76.1 in the second period (1997 to 2006) (P<0.00008). The incidence of new cases increased 2.6-fold comparing both periods of time. This study consisted of 467 females and 382 males, with a mean age at diagnosis of 31.3+/-12.3 years. The clinical manifestations were pancolitis (59.1%), and extraintestinal manifestations (41.5%). Most of the patients, 762 (89.8%) were taking sulfasalazine or 5-aminosalicylic acid, 282 (33.3%) used oral or systemic steroids, 237 (28%) were taking azathioprine.
CONCLUSIONS: The frequency of new UC cases has increased significantly in the last 10 years in Mexico, largely due to the unique genetic make-up and the environmental factors (infectious diseases including parasites) not found in other countries.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19057395     DOI: 10.1097/MCG.0b013e31817a76b4

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  19 in total

1.  Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study.

Authors:  Jesús K Yamamoto-Furusho; Andrea Sarmiento-Aguilar
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

2.  Association of the interleukin 15 (IL-15) gene polymorphisms with the risk of developing ulcerative colitis in Mexican individuals.

Authors:  Jesus K Yamamoto-Furusho; Jorge L De-León-Rendón; Edith Alvarez-León; Mario Valdivia-Eziquio; Claudia Obil-Chavarría; Gilberto Vargas-Alarcón
Journal:  Mol Biol Rep       Date:  2014-01-11       Impact factor: 2.316

Review 3.  Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis.

Authors:  Danny J Avalos; Antonio Mendoza-Ladd; Marc J Zuckerman; Mohammad Bashashati; Andres Alvarado; Alok Dwivedi; Oriana M Damas
Journal:  Dig Dis Sci       Date:  2018-03-29       Impact factor: 3.199

Review 4.  Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis.

Authors:  Maurizio Bellavia; Giovanni Tomasello; Marcello Romeo; Provvidenza Damiani; Attilio I Lo Monte; Luciano Lozio; Claudia Campanella; Antonella Marino Gammazza; Francesca Rappa; Giovanni Zummo; Massimo Cocchi; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello
Journal:  Med Microbiol Immunol       Date:  2013-07-18       Impact factor: 3.402

5.  Factors Associated with the Presence of Extraintestinal Manifestations in Patients with Ulcerative Colitis in a Latin American Country.

Authors:  Jesús K Yamamoto-Furusho; Germán E Sánchez-Morales
Journal:  Inflamm Intest Dis       Date:  2020-10-14

6.  Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.

Authors:  Fausto Sánchez-Muñoz; Gabriela Fonseca-Camarillo; Marco A Villeda-Ramírez; Elizabeth Miranda-Pérez; Edgar J Mendivil; Rafael Barreto-Zúñiga; Misael Uribe; Rafael Bojalil; Aarón Domínguez-López; Jesús K Yamamoto-Furusho
Journal:  BMC Gastroenterol       Date:  2011-12-20       Impact factor: 3.067

7.  Inflammatory Bowel Disease in Hispanics: The University of Puerto Rico IBD Registry.

Authors:  Esther A Torres; Abdiel Cruz; Mariola Monagas; Marina Bernal; Yadira Correa; Rafael Cordero; Víctor L Carlo
Journal:  Int J Inflam       Date:  2011-12-11

8.  Latitude, sunshine, and human lactase phenotype distributions may contribute to geographic patterns of modern disease: the inflammatory bowel disease model.

Authors:  Andrew Szilagyi; Henry Leighton; Barry Burstein; Xiaoqing Xue
Journal:  Clin Epidemiol       Date:  2014-05-27       Impact factor: 4.790

9.  Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire.

Authors:  Nallely Bueno-Hernández; Martha Núñez-Aldana; Ilse Ascaño-Gutierrez; Jesús K Yamamoto-Furusho
Journal:  Nutr J       Date:  2015-03-14       Impact factor: 3.271

10.  Positive association between leptin serum levels and disease activity on endoscopy in inflammatory bowel disease: A case-control study.

Authors:  Fabiola Trejo-Vazquez; Idalia Garza-Veloz; Gabriela Alejandra Villela-Ramirez; Yolanda Ortiz-Castro; Panfilo Mauricio-Saucedo; Edith Cardenas-Vargas; Mariana Diaz-Baez; Miguel A Cid-Baez; Rodrigo Castañeda-Miranda; Jose Manuel Ortiz-Rodriguez; Luis Octavio Solis-Sanchez; Margarita L Martinez-Fierro
Journal:  Exp Ther Med       Date:  2018-02-05       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.